You are here: Industry Insights > CVD

News List

How Africa, Asia could benefit from Ticagrelor’s WHO listing SHEM OIRERE
April 19, 2023
Anglo-Swedish multinational pharmaceutical and biotechnology company, AstraZeneca Plc, has recently applied to World Health Organization for the inclusion of Ticagrelor.
Clinical Decision Support May Cut Cardiovascular Disease Risk drugs.com
February 10, 2022
Use of clinical decision support systems (CDSSs) is associated with improvements in reversible risk for cardiovascular disease.
Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis drugs.com
January 19, 2022
Dermatologists and patients with psoriatic disease have a positive view of a specialist-led model of care to improve cardiovascular...
First-of-its-kind NHS gene pilot takes off pharmatimes
January 18, 2022
The NHS launches world-first study investigating genetic testing for common diseases.
USPSTF: Individualize Counseling for Primary Prevention of CVD drugs.com
January 18, 2022
The U.S. Preventive Services Task Force (USPSTF) recommends that physicians individualize the decision to refer adults without...
Global Fitness Tracker Market Research Report 2021: Market Players Introduced Some Covid-19-Specific Tracking Indications to Capture the Growing Market Demand prnewswire
August 19, 2021
The global fitness tracker market size is expected to reach USD 138.7 billion by 2028, registering a CAGR of 18.9%
Beckman Coulter to Distribute BNP Cardiac Assay to Customers prnasia
July 27, 2021
Beckman Coulter, a global clinical diagnostics leader, announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture, distribution, and sale of a BNP assay for Beckman Coulter analyzers.
Prior Statin Use Linked to Reduced Risk for Death in COVID-19 drugs
July 22, 2021
For patients hospitalized with COVID-19, prior use of statins, with or without antihypertensives, is associated with a reduced risk for death, according to a study published online July 15 in PLOS ONE.
GENinCode, EVERSANA Enter Major U.S. Commercialization Pact contractpharma
June 15, 2021
EVERSANA will support launch and commercialization in the U.S. market for GENinCode’s portfolio of polygenic cardiovascular disease products.
Amgen announces NHS collaboration aiming to tackle high cholesterol pharmatimes
October 10, 2020
Amgen has announced a new partnership with two NHS organisations with the aim of tackling the ‘silent killer’ of high cholesterol across the North West Coast of England.

Previous page 1 2 3 4 5 Next page